Gastroretentive drug delivery systems: A holy grail in oral delivery

Research output: Contribution to journalReview articlepeer-review

Abstract

Gastroretentive drug delivery systems (GRDDSs) offer a promising strategy for enhancing oral drug bioavailability by prolonging gastric residence time and enabling site-specific drug release. This review examines the key materials used in GRDDSs, including polymers for controlled drug release, gas-generating agents for buoyancy, and mucoadhesive components for improved retention and stability. Advances in fabrication techniques, such as 3D printing, spray drying, and nanoparticle encapsulation, have enabled precise modulation of drug release kinetics and retention properties. However, challenges such as inter-subject variability, physiological constraints, and manufacturing scalability remain. Future research will focus on smart materials, multi-drug platforms, and expanding applications to biologics and nutraceuticals, paving the way for more effective and patient-compliant oral drug delivery systems.

Original languageEnglish
Article number104340
JournalDrug Discovery Today
Volume30
Issue number4
DOIs
StatePublished - Apr 2025

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Ltd

ASJC Scopus Subject Areas

  • Pharmacology
  • Drug Discovery

Keywords

  • controlled release systems
  • enhanced bioavailability
  • Gastric retention platforms
  • gastroretentive technologies
  • mucoadhesive drug delivery

Fingerprint

Dive into the research topics of 'Gastroretentive drug delivery systems: A holy grail in oral delivery'. Together they form a unique fingerprint.

Cite this